Board Meeting3 Aug 2026, 05:30 pm
Amerise Biosciences Ltd Declares Un-audited Q1 FY27 Results
AI Summary
Amerise Biosciences Ltd announced that its Board of Directors, in a meeting held on August 3, 2026, approved the un-audited financial results for the quarter ended June 30, 2026. The results were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors. The company operates in a single segment. The board meeting commenced at 04:50 PM and concluded at 05:10 PM.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Results pertain to the quarter ended June 30, 2026.
- Financial results were reviewed by the Audit Committee.
- Statutory auditors conducted a limited review.
- Company operates in a single business segment.
Price Impact
More from AMERISE